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The monomeric RalGTPases, RalA and RalB
are recognized as components of a regulatory
framework supporting tumorigenic transforma-
tion. Specifically, RalB is required to suppress
apoptotic checkpoint activation, the mechanis-
tic basis of which is unknown. Reported effector
proteins of RalB include the Sec5 component of
the exocyst, an octameric protein complex im-
plicated in tethering of vesicles to membranes.
Surprisingly, we find that theRalB/Sec5 effector
complexdirectly recruits andactivates the atyp-
ical IkB kinase family member TBK1. In cancer
cells, constitutive engagement of this pathway,
via chronic RalB activation, restricts initiation
of apoptotic programs typically engaged in the
context of oncogenic stress. Although dispens-
able for survival in a nontumorigenic context,
this pathway helps mount an innate immune re-
sponse to virus exposure. These observations
define the mechanistic contribution of RalGT-
Pases to cancer cell survival and reveal the
RalB/Sec5 effector complex as a component
of TBK1-dependent innate immune signaling.
INTRODUCTION
Much attention has focused over the past two decades
on identifying the molecular basis of the participation of
oncogenic Ras in tumor initiation and progression. The
proximal participation of Ras proteins in the activation of
Raf family and PI3K family kinases has been well estab-
lished together with the mechanistic participation of these
Ras effectors in normal and aberrant regulatory networks(Downward, 2003; Mitin et al., 2005; Repasky et al., 2004).
However, activation of RalGTPases has historically been
the orphan Ras effector pathway with respect to a func-
tional andmechanistic understanding of its role in Ras sig-
naling and oncogenic transformation (Camonis andWhite,
2005; Feig, 2003). The RalGTPases, RalA and RalB, are
close relatives of the founding members of the Ras
GTPase superfamily. They are engaged in response to a
broad variety of mitogenic, trophic, and hormonal signals
by a diverse group of guanyl nucleotide exchange factors
that fall into two major groups: those that are directly Ras-
responsive via a carboxyterminal Ras binding domain and
those that are apparently mobilized by phosphoinositide
second messengers via a carboxyterminal pleckstrin
homology domain (Feig, 2003).
Recently, a confluence of observations has exposed a
central and critical contribution of RalGTPase activation
to the initiation and maintenance of oncogenic transfor-
mation. Genetically defined human cell models of tumor
progression suggest that RalGTPase activation is an es-
sential component of oncogenic Ras-induced transforma-
tion in a broad variety of human epithelial cells and is
sufficient to drive tumorigenic phenotypes in some back-
grounds (Hamad et al., 2002; Rangarajan et al., 2004).
RNAi-mediated loss-of-function analysis demonstrated
that RalA and RalB collaborate to both support enhanced
proliferative propensity and restrict cell-death programs
(Chien and White, 2003). Finally, genetic ablation of
RalGDS, a Ras-responsive guanyl nucleotide exchange
factor, reduced the incidence and progression of topical
carcinogen-induced dermal papillomas (Gonzalez-Garcia
et al., 2005).
Several candidate and bona fide RalGTP effector pro-
teins have been identified that implicate the participation
of these proteins in a bewildering array of dynamic cell
biological processes. These include a protein with Rac/
CDC42 GAP activity, RalBP1/RLIP, that may participateCell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc. 157
Figure 1. Sec5 is the RalB Effector Supporting Human Tumor Cell Survival
(A) Sec5 deficiency is selectively toxic in cancer cell lines. The indicated human cell lines were transfected with a targetless control siRNA (C) or siRNA
targeting human Sec5. Apoptotic cells were scored 72 hr posttransfection and are represented as a percentage of the total cell population ± SD from
three independent experiments. The presence of cleaved poly(adenosine diphosphate-ribose)polymerase (DPARP) from parallel experiments is
shown beneath the graph as an indication of relative caspase activity. Efficacy of RNAi was verified by immunoblots of whole-cell lysates with
anti-Sec5 antibodies and ERK1/2 are shown as loading controls. Identical results were observed with an independent siRNA targeting Sec5.
(B) RalA depletion desensitizes cells to loss of Sec5. HeLa cells were transfected with the indicated siRNAs and apoptosis was scored by TUNEL
labeling 72 hr posttransfection. Error bars represent mean ± SD of three independent experiments.
(C) An aliquot of cells from (B) was stainedwith propidium iodide and DNA content was analyzed by FACS. Apoptotic cells appear as a population with
sub-G1 signal intensities as a consequence of DNA fragmentation. Representative results from three independent experiments are shown.
(D) Transformed cells display elevated RalGTPase activation. GST-Sec5rbd was used to immobilize endogenous GTP-bound RalA and RalB from the
indicated cell lines.158 Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc.
Figure 2. TBK1 Is a Sec5-Interacting
Protein
(A) Endogenous TBK1 associates with the
exocyst. Anti-Sec8 immunoprecipitates from
human bronchial epithelial cells (HBECs) were
immunoblotted for the presence of endoge-
nous TBK1 and representative exocyst sub-
units. Normal mouse IgG (mIgG) was used as
a negative control.
(B) TBK1 interacts with Sec5. 293 cells were
transfected as indicated and I.P.s were blotted
for the presence of FLAG-TBK1 and HA-Sec5.
(C) The minimal Ral-binding domain of Sec5 is
sufficient for TBK1 association. The indicated
I.P.s were blotted for the presence of FLAG-
TBK1 and Myc-Sec5rbd.
(D) Sec5rbd interacts directlywith TBK1 in vitro.together with Ral to regulate a subset of endocytic path-
ways; filamin, a structural protein that may participate
in Ral-dependent filopodia formation; and the exocyst
subunits Sec5 and Exo84 that mediate Ral regulation of
dynamic secretory vesicle targeting and tethering pro-
cesses (Camonis and White, 2005; Feig, 2003; Moska-
lenko et al., 2003).
Here, we have directly investigated the relative contri-
bution of RalGTPase effector proteins to Ral function in
normal and tumorigenic human epithelial cells in order to
define the regulatory pathway directly engaged by RalB
to support tumor cell survival. Surprisingly, we find that
a RalB/Sec5 effector complex specifically supports the
prosurvival arm of tumorigenic regulatory networks by di-
rectly recruiting and activating the atypical IkB kinase
family member TBK1 (Tank binding kinase 1). While this
process is physically tethered to the exocyst complex, it
may be distinct from the participation of RalB or Sec5 in
exocyst assembly or function.We show that TBK1 kinases
are chronically activated in a variety of cancer cell lines,
are required to maintain cancer cell survival, and are re-
quired to support oncogenic Ras-induced transformation.
Although dispensable for survival of nontumorigenic hu-
man epithelial cells in culture, this pathway helps mount
an innate immune response to dsRNA or Sendai virus
exposure. Therefore, the RalB/Sec5 effector complex is
a component of host defense signaling, acting directly at
the level of TBK1 activation. These observations define
the direct mechanistic contribution of RalB to oncogenic
transformation, expose a central component of the proxi-
mal machinery required to engage TBK1 in response
to antiviral surveillance systems, and reveal the contribu-
tion of components of cell-autonomous innate immunepathways to the generation of a tumorigenic regulatory
framework.
RESULTS
Sec5 Is the RalB Effector Restricting Apoptosis
in Cancer Cells
To define the molecular nature of the RalB effector path-
way supporting cancer cell survival, we first carried out
an RNAi-based candidate screen of RalGTPase effector
proteins. Our expectation was that depletion of the bona
fide effector protein supporting this pathway would phe-
nocopy RalB depletion: selective induction of apoptosis
in cancer cells versus nontumorigenic epithelial cells
(Chien and White, 2003). While depletion of the Ral effec-
tors Exo84 (Moskalenko et al., 2003) or RLIP/RalBP1
(Cantor et al., 1995; Jullien-Flores et al., 1995; Park and
Weinberg, 1995) did not uncover any overt contribution
of these proteins to cell proliferation or survival (data not
shown), depletion of the Ral effector Sec5 (Moskalenko
et al., 2002; Sugihara et al., 2002) with multiple indepen-
dent siRNA duplexes induced apoptosis in a variety of hu-
man tumor-derived cell lines (Figure 1A). In contrast, Sec5
was not limiting for survival of normal nontumorigenic
telomerase-immortalized humanmammary epithelial cells
(HME) or bronchial epithelial cells (HBEC; Figure 1A).
However, as we previously observed upon depletion of
RalB (Chien and White, 2003), depletion of Sec5 did sen-
sitize HME cells to apoptosis in response to a 16 hr release
from matrix association (35% of the population as com-
pared to 9.5% in control groups). We have previously
observed that RalA-dependent pathological proliferative
pressure is offset by RalB-dependent inhibition of(E) Sec5 supports cell survival independently of exocyst function. HeLa cells were transfected with the indicated siRNAs. Ninety-six hours posttrans-
fection, cells were labeled with TUNEL and counterstained with DAPI as shown. Representative results from three independent experiments are
shown.Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc. 159
Figure 3. TBK1 Depletion Mimics RalB and Sec5 Depletion
(A) TBK1 deficiency triggers apoptosis. HeLa cells were transfected with the indicated siRNAs. Apoptosis was assayed by TUNEL labeling 72 hr post-
transfection. Error bars represent mean ± SD of three independent experiments.
(B) A highly penetrant cell-death phenotype results from long-term TBK1 depletion. HeLa cells were transfected as in (A) except that apoptosis was
scored by TUNEL-labeling 120 hr posttransfection. Representative results from three independent experiments are shown.
(C) RalA depletion desensitizes cells to loss of TBK1. The apoptotic response to the indicated siRNAs was evaluated as in (A).
(D) Selective dependence of tumorigenic cell lines on TBK1 for survival. The indicated cell lines were assessed as in (A).apoptosis (Camonis and White, 2005; Chien and White,
2003). Consistent with this observation, we find higher rel-
ative amounts of activated RalA and RalB in transformed
cell lines relative to related nontumorigenic cell lines (Fig-
ure 1D). As a result of this yin-yang relationship, depletion
of RalA relieves the dependency of cancer cells on RalB-
dependent survival signaling (Chien and White, 2003).
Importantly, depletion of RalA also reduced the sensitivity
of tumor cells to loss of Sec5 (Figures 1B and 1C). The
observation that Sec5 depletion mimics RalB depletion
in multiple backgrounds strongly implicates Sec5 as the
immediate downstream effector supporting RalB survival
signaling.
Sec5 is a member of the heterooctameric Sec6/8 com-
plex, a.k.a. theexocyst, responsible for regulated targeting
and tethering of selective secretory vesicles to specialized
dynamic plasma membrane domains (Guo et al., 2000).
The sum of observations to date suggest that RalGTPases160 Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc.regulate a Sec5-Exo84 assembly interface for dynamic
control of exocyst function in mammalian cells (Moska-
lenkoet al., 2002, 2003). TheconsequencesofSec5deple-
tion described above imply a role for secretory machinery
in the maintenance of cancer cell survival. However, in
contrast to Sec5, depletion of the exocyst subunits Sec6
or Exo84 did not impair cell viability (Figure 1E), suggesting
that the contribution of Sec5 to cancer cell survival may be
in addition to but separate from its role as a component of
the exocyst.
TBK1 Is a Sec5-Interacting Protein Supporting
Cancer Cell Survival
To generate leads for discovery of themechanistic basis of
Sec5-dependent cancer cell survival, we examined the
molecular composition of the exocyst complex in human
epithelial cells. The endogenous exocyst was immuno-
isolated using monoclonal a-Sec8 antibodies that were
Figure 4. Ral Induces TBK1 Kinase Acti-
vation
(A) Ral activation promotes assembly of Sec5/
TBK1 complexes. FLAG-TBK1 expressed
alone or together withMyc-RalF39Lwas immu-
noprecipitated from 293 cells and assayed for
associated endogenous Sec5 as indicated.
(B) Both Ral and Sec5rbd are sufficient to trig-
ger TBK1 activation. FLAG-TBK1 expressed
alone or together with Myc-RalF39L, Myc-
Sec5rbd, or HA-Sec5 was immunoprecipitated
from 293 cells and kinase activity was evalu-
ated in vitro using recombinant IRF-3-C as
the substrate. 32P incorporation as visualized
by phosphorimager analysis following SDS-
PAGE is shown. Relative amounts of immuno-
precipitated TBK1 are shown.
(C) Ral activation of IRF-3 is Sec5 and TBK1 de-
pendent. HBECs were transfected with Myc-
RalF39L together with the indicated siRNAs.
Seventy-two hours posttransfection, endoge-
nous IRF-3 localization in Ral-transfected cells
was examined by immunofluorescence. Error
bars represent mean ± SD of three indepen-
dent experiments. Representative cells trans-
fected with RalF39L are shown. Nuclear accu-
mulation of endogenous IRF-3 is indicated by
the arrowheads.
(D) Ral is sufficient to activate the IFN-b pro-
moter. Osteosarcoma cells were cotransfected
with CMV promoter regulated Renilla lucifer-
ase, and IFN-b promoter regulated firefly
luciferase reporter together with the indicated
constructs. Cells were incubated for 24 hr, har-
vested, and extracts subjected to a standard
dual luciferase assay. Bars indicate relative
IFN-b luciferase activity ± SD.
(E) Ral is required for Sendai virus-induced
activation of the IFN-b promoter. Cells were
treated as in (D) except with an additional 20
hr incubation in the presence or absence of
Sendai virus (100 HA/ml). Bars indicate relative
IFN-b luciferase activity ± SD.
(F) Viral infection promotes assembly of Sec5/
TBK1 complexes. FLAG-TBK1 was immuno-
precipitated from HBEC cells and assayed for
associated Sec5 as indicated 5 hr postinfection
with Sendai virus (100 HA/ml).previously shown to effectively precipitate the full octa-
meric complex (Grindstaff et al., 1998). The proteins in
the complex were identified by nano-HPLC electrospray
ion trapmass spectrometry following 1D gel chromatogra-
phy (Zhao et al., 2004a). From each of three independent
analyses of complexes recovered from the triton-soluble
fraction of cell lysates, we identified the exocyst compo-
nents Sec8, Sec3, Sec5, Sec6, and Sec10 together with
the atypical IkB kinase (IKK) family member TBK1/NAK
(Tank binding kinase 1/NFkB activating kinase). The pres-
ence of TBK1 in the exocyst complex was validated
by immunoblot analysis of a-Sec8 immunoprecipitates
(Figure 2A).
While TBK1/ mouse embryo fibroblasts proliferate
normally in culture, genetic ablation of TBK1 is embryoniclethal, suggesting TBK1 supports cell survival during
development (Bonnard et al., 2000). TBK1 has recently
been recognized as a central component of the regulatory
network supporting host defense responses. TBK1 can di-
rectly phosphorylate both the p65 Rel and IRF-3 transcrip-
tion factors, enhancing their transactivating potential, and
is required for IRF-3 activation in response to viral invasion
(Buss et al., 2004; Fitzgerald et al., 2003; McWhirter et al.,
2004; Sharma et al., 2003). Intriguingly, both IRF-3 and its
close homolog IRF-7 have been implicated in promotion
of oncogenic transformation (Lubyova et al., 2004; Zhang
et al., 2004). Given these relationships, we investigated
the possible contribution of TBK1 to RalB/Sec5-depen-
dent survival signaling. In vitro binding assays, using re-
combinant TBK1 together with individual exocyst subunitsCell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc. 161
Figure 5. Ral Binding Exposes a Sec5/TBK1 Interaction Interface
(A) Active Ral blocks Sec5 dimerization. 293 cells were transfected with the indicated plasmids. Forty-eight hours posttransfection, HA-Sec5 was
immunoprecipitated and assayed for coprecipitating Myc-Sec5rbd in the presence or absence of RalF39L expression.
(B) Ral and TBK1 do not compete for Sec5rbd binding. FLAG-TBK1 was immunoprecipitated and assayed for coprecipitating Sec5rbd in the pres-
ence or absence of RalF39L expression.
(C) Kinase-domain-dependent inhibition of Sec5 dimerization by TBK1. The association of HA-Sec5 with Myc-Sec5rbd and endogenous Sec8 was
examined in the presence or absence of wild-type FLAG-TBK1 (WT) or kinase-dead FLAG-TBK1-K38A (KD) expression.
(D) Both wild-type and kinase-dead TBK1 bind Sec5rbd. The presence of the indicated proteins was examined in Myc-Sec5rbd immunoprecipitates.
(E) TBK1 phosphorylates Sec5rbd. FLAG-TBK1 expressed in 293 cells was immunoprecipitated and incubated with purified recombinant GST-
RLIPrbd or GST-Sec5rbd together with 32P-ATP.162 Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc.
produced in rabbit reticulocyte lysates, identified Sec5 as
the TBK1-interacting exocyst subunit (data not shown).
This was validated with reciprocal coimmunoprecipitation
of epitope-tagged TBK1 and Sec5 from HEK293 cells
(Figure 2B). Truncation analysis identified the amino termi-
nus of Sec5 as minimally sufficient for TBK1 interaction
(Figure 2C). This region completely overlaps with the pre-
viously defined Ral-binding domain of Sec5 (Sec5rbd,
amino acids 1–120) that directly interacts with activated
RalGTPases (Moskalenko et al., 2002; Sugihara et al.,
2002). Sec5rbd also directly interacted with TBK1 in vitro
(Figure 2D); however, this interaction is not a common fea-
ture among ‘‘Ral-binding domains,’’ as a distinct minimal
Ral-binding domain from the candidate Ral effector
RalBP1/RLIP did not bind TBK1 (Figure 2D).
We examined the potential functional relevance of
TBK1/Sec5 complexes through siRNA-mediated loss of
function. Mimicking the consequences of RalB or Sec5
deficiency, cells depleted of TBK1 engaged an asynchro-
nous apoptotic program, such that approximately 25% of
the population scored positive for apoptotic markers at
any one time (Figure 3A) and the majority of the cells
were dead by 150 hr posttransfection (Figure 3B). Code-
pletion of Sec5 together with TBK1 did not appreciably
alter the apoptotic response as compared to depletion
of either alone, implying action on a common pathway
(Figure 3A). Consistent with a functional interaction of
TBK1 with RalB and Sec5, this phenotype was rescued
by codepletion of RalA (Figure 3C). Finally, like RalB and
Sec5, TBK1 is a limiting factor for survival of a variety of
tumor-derived cell lines but not nontumorigenic epithelial
cells (Figure 3D).
RalB Activates TBK1 by Promoting Sec5/TBK1
Complex Assembly
The portion of Sec5 participating in both RalGTP and
TBK1 binding is an immunoglobulin-like structure similar
to the NFkB p50 dimerization domain that falls into the
IPT/TIG family of protein domains (Fukai et al., 2003).
Given that GTP-bound RalB and TBK1 directly interact
with the same domain in Sec5, we examined the conse-
quences of RalGTPase regulation on the Sec5/TBK1
complex and TBK1 kinase activity. Expression of a ‘‘fast
exchange’’ variant of Ral that constitutively activates Ral
regulatory pathways in cells without grossly interfering
with exocyst function (Moskalenko et al., 2002) promoted
TBK1 association with endogenous Sec5 (Figure 4A). This
indicates that, in contrast to potential steric hindrance,
Ral activation drives TBK1/Sec5 complex assembly.
Importantly, Ral-induced TBK1/Sec5 complex formation
correlated with enhanced TBK1 kinase activity as mea-
sured by in vitro phosphorylation of recombinant IRF-3,
a direct TBK1 substrate (Fitzgerald et al., 2003; Sharma
et al., 2003; Figure 4B). Surprisingly, expression of theSec5rbd, which is minimally sufficient for direct TBK1 in-
teraction, was also sufficient to enhance TBK1 kinase
activity. In contrast, expression of full-length Sec5 had
no impact on TBK1 activation (Figure 4B). As mentioned
above, a direct downstream consequence of TBK1 activa-
tion is phosphorylation of the cytoplasmic IRF-3 transcrip-
tion factor. This modification induces IRF-3 dimerization
and nuclear translocation to trigger interferon-response
gene-expression programs (Fitzgerald et al., 2003; Sharma
et al., 2003). Consistent with a RalB/Sec5/TBK1 regulatory
cascade, expression of activated Ral in normal human
bronchial epithelial cells was sufficient to induce Sec5-
and TBK1-dependent nuclear translocation of endogenous
IRF-3 (Figure 4C). In further support of this relationship,
RalB was sufficient to activate expression of a luciferase
reporter gene driven by the IRF-3-responsive Interferon-
b (IFN-b) promoter (Figure 4D; Foy et al., 2003). In addition,
Sendai virus-induced activation of the IFN-b promoter
was severely abrogated upon inhibition of endogenous
Ral protein function by expression of a dominant interfer-
ing RalGTP binding domain from RLIP/RalBP1 (RLIPrbd
[Moskalenko et al., 2002]; Figure 4E). Finally, we found
that Sec5/TBK1 complexes accumulate in response to
host defense pathway activation by Sendai virus infection
(Figure 4F).
The differential capacity of Sec5rbd versus full-length
Sec5 to induce TBK1 activation, coupledwith our previous
observations that Sec5 can self-associate (Formstecher
et al., 2005), suggested the possibility that RalB may pro-
mote Sec5/TBK1 association and TBK1 activation by re-
lieving autoinhibitory interactions within the Sec5 protein.
We found that Sec5 and Sec5rbd interacted robustly in
cells and that activated Ral could effectively block this in-
teraction (Figure 5A). In contrast, expression of activated
Ral did not detectably modulate the interaction between
TBK1 and Sec5rbd (Figure 5B). This suggests that while
RalB and TBK1 have independent interaction interfaces
on Sec5rbd, RalB can sterically hinder Sec5 self-associa-
tion. Intriguingly, the Sec5/Sec5rbd interaction was also
blocked by expression of TBK1 but in a manner that was
dependent on TBK1 kinase activity (Figure 5C). Both
wild-type and kinase-dead TBK1 coprecipitated equiva-
lently well with Sec5rbd (Figure 5D), indicating that the
capacity of TBK1 to dissociate Sec5/Sec5rbd complexes
was not a consequence of competitive interactions. How-
ever, TBK1 can directly phosphorylate Sec5rbd (Fig-
ure 5E), raising the possibility that TBK1 kinase activity
may stabilize an ‘‘open conformation’’ of Sec5—possibly
facilitating feedback amplification of TBK1 activation.
The cumulative relationships described above suggest a
two-step model for Ral-induced TBK1 activation, in which
RalB/Sec5 complex formation reveals a cryptic TBK1-in-
teractiondomain that recruits TBK1 intoa kinase activation
complex. Consistent with the capacity of RalB tomodulate(F) RalB activation modulates endogenous TBK1 complexes. MDCK cells were transfected with vector (top panels) or RalB23V (bottom panels).
Forty-eight hours posttransfection, cleared lysates were fractionated by FPLC. Fractions 12–40 were immunoblotted with the indicated antibodies.
Molecular weight standards eluted at the indicated fractions.Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc. 163
Figure 6. RalB and Sec5 Are Required for Host Defense Pathway Activation
(A) RalGTPases are activated in response to TLR3 signaling. HBECs were treated with poly(I:C) (100 mg/ml) for the indicated time points (0, 5, 10, 15
min). GST-Sec5rbdwas used to immobilize endogenous GTP-bound RalA and RalB. Phospho-IRF-3 (Ser396) fromwhole-cell lysates (WCL) is shown
to indicate responsiveness to poly (I:C).
(B) RasGTPases are inactivated in response to TLR3 signaling. HBECs were treated as in (A). GST-Raf1rbd was used to immobilize endogenous
GTP-bound Ras.
(C) RalB is activated in response to Sendai virus infection. HBECs were exposed to Sendai virus (100 HA/ml) for the indicated times and assessed for
RalB activation as in (A).
(D) RalB and Sec5 are required for IRF-3 but not p65 responsiveness to TLR3 activation. HBECs were cotransfected with a plasmid expressing GFP
together with the indicated siRNAs. This method delivers RNA and DNA into a small subset of the population, which can be monitored by GFP
expression and allows observation of potentially defective responses within a background of appropriately responding cells. Seventy-two hours164 Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc.
dynamic TBK1 protein/protein interactions, we found that
RalB activation was sufficient to promote the formation of
high molecular weight TBK1 complexes, as assessed by
size exclusion chromatography that cofractionated with
a subpopulation of Sec5 in MDCK cells (Figure 5F). These
combined observations indicate a physiologically relevant
mechanistic relationship among RalB, Sec5, and TBK1 in
which RalB drives TBK1 activation directly through Sec5
to support cancer cell survival.
The RalB/Sec5 Effector Pathway Supports Host
Defense Signaling
Both genetic and biochemical analysis has firmly posi-
tioned TBK1 as a central component of the innate immune
responsepathways that connect detection of viral invasion
to induction of host defense gene expression programs
(Balachandran et al., 2004; Fitzgerald et al., 2003). Given
the observation that RalB can promote TBK1 activation
through Sec5, we investigated the contribution of RalB
and Sec5 to the TBK1-dependent host defense response.
Exposure of telomerase-immortalized human bronchial
epithelial cells (HBECs) to polyinosine-polycytidylic acid
(poly(I:C)), a synthetic mimic of viral dsRNA, resulted in
the activation of endogenous RalGTPases within 5–10
min (Figure 6A), suggesting Ral activation is an immediate
early response to innate immune signaling triggered by
Toll-like receptor 3 (TLR3) and/or MDA5 (Alexopoulou
et al., 2001; Kato et al., 2006; Kawai et al., 2005; Lee
et al., 2006). On the other hand, Ras activation was sup-
pressed, suggesting dsRNA surveillance couples to Ral
activation in a Ras-independent manner (Figure 6B). In
addition, exposure of HBECs to Sendai virus induced ac-
cumulation of RalB-GTP by 6 hr postinfection (Figure 6C).
SiRNA-mediated depletion of RalGTPases and exocyst
subunits revealed that poly(I:C)-induced mobilization of
IRF-3 nuclear translocation in HBECs was dependent
upon endogenous RalB and Sec5. In contrast, RalA andSec8 were not limiting for this response (Figures 6D and
6E). Poly(I:C)-induced mobilization of p65 NFkB nuclear
accumulation is independent of TBK1, bifurcating at the
level of TRIF (TIR domain-containing adaptor-inducing
IFN; Sato et al., 2003; Yamamoto et al., 2003). Neither
RalB nor Sec5 depletion interfered with poly(I:C)-induced
p65 nuclear accumulation (Figure 6D). This indicates that
in the absence of RalBor Sec5, thedsRNA receptor signal-
ing system is still functional but is selectively impaired for
TBK1 activation. Depletion of Sec5, but not RalA, also
blocked poly(I:C) induction of endogenous IRF-3-depen-
dent gene expression (Figure 6F). Activation of IRF-3 and
induction of type I interferon expression in response to
Sendai virus infection was also Sec5 dependent (Figures
6G, 6H, and 6I). The exocyst has recently been implicated
as a central component of the vesicle traffickingmachinery
required for the fission step of cytokinesis in epithelial cells
(Gromley et al., 2005). Our group and others have directly
implicated RalA in the assembly and function of the exo-
cyst (Camonis and White, 2005; Moskalenko et al., 2002,
2003; Shipitsin and Feig, 2004). In concordance with a
distinct separation of function of RalA and RalB in HBECs,
depletion of RalA, but not RalB, resulted in amarked accu-
mulation of binucleated cells, presumably resulting from
cytokenesis defects (Figure 6J). Our cumulative observa-
tions indicate that RalB and Sec5 are direct and obligate
components of the TBK1-dependent innate immune
mechanism in normal nontumorigenic human epithelial
cells. The role of Sec5 is likely in addition to, but distinct
from, its occupation as a central exocyst component.
To examine the contribution of Ral and Sec5 to the host
defense response in vivo, we examined the Toll pathway-
dependent antimicrobial response in Drosophila. Homo-
zygous deletions of dRal or dSec5 result in early embry-
onic lethality (Murthy et al., 2003). However, flies with a
single copy of dSec5 or with hypomorphic mutations in
dRal are viable. Fungal infection-induced expression ofposttransfection, cells were treated with poly(I:C) as indicated for 90 min. Endogenous IRF-3 or p65 (NF-kB) compartmentalization was examined by
immunostaining with the appropriate antibodies. Representative cells from three independent experiments are shown.
(E) HBECs were transfected, using a high-efficiency protocol, with the indicated siRNAs. Seventy-two hours posttransfection, cells were treated as in
(D). Endogenous IRF-3 was examined as in (D). Representative cells from three independent experiments are shown.
(F) Sec5 is required to trigger interferon response gene expression. HBECs were transfected as in (E) with the indicated siRNAs then treated with
poly(I:C). Total RNAwas isolated for RT-PCR using primers specific for ISG56 andGAPDH. Representative results from two independent experiments
are shown.
(G) Sec5 is required for viral activation of IFN-b. Cells were treated as in (F) except that poly(I:C) was substituted with a 17 hr exposure to Sendai virus
(100 HA/ml). Total RNA was isolated for RT-PCR using primers specific for IFN-b and GAPDH. Representative results from two independent exper-
iments are shown.
(H) Sec5 is required to trigger IRF-3 activation in response to Sendai virus exposure. Seventy-two hours following transfection with the indicated
siRNAs, HBECs were exposed to Sendai virus (100 HA/ml) for 17 hr. Endogenous IRF-3 nuclear accumulation was scored following immunostaining
as in (D). Error bars represent mean ± SD.
(I) Sec5 is required for IFN-b production in response to Sendai virus exposure. HBECs were treated as in (H). Culture supernatants were collected,
cleared by centrifugation, and IFN-b concentrations measured by ELISA. Error bars represent mean ± SD.
(J) RalA deficiency results in defective cytokinesis. HBECs transfected with the indicated siRNAs were labeled with rhodamine-phalloidin and DAPI.
The number of binucleated cells in each group was scored and normalized to the nontargeting siRNA control. The relative fold change ± SD is shown
together with representative fluorescence micrographs.
(K) dSec5 and dRal participate in the Drosophila antimicrobial response. Septic injuries were produced by pricking 3- to 6-day-old male adults of the
indicated genotypes (20 animals for each group) with a needle coated with a mixture of Gram-negative bacteria (Erwinia carotovora carotovora) and
fungi (Candida albicans). Ten hours later, total RNAwas extracted and evaluated by quantitative real-time RT-PCR forDrosomycin (Drs) and ribosomal
protein 49 (rp49) gene expression. Values indicate Drs expression, normalized to rp49, relative to the response in wild-type control animals (arbitrarily
set at 100). Error bars indicate standard deviation from the mean from three independent experiments.Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc. 165
Figure 7. TBK1 Is Required for Oncogenic Ras-Induced Transformation
(A) TBK/ cells do not tolerate acute oncogenic Ras expression. Wild-type (WT) and TBK1/ mouse embryonic fibroblasts (MEFs) were infected
with replication-defective retrovirus encoding GFP (as a control) or K-Ras12V. Forty-eight hours postinfection, apoptosis was scored by TUNEL. Error
bars represent mean ± SD. Representative phase-contrast images of cell monolayer morphology are shown below the graph.
(B) An aliquot of cells from (A) was lysed and analyzed by SDS-PAGE with the indicated antibodies.
(C) Loss of TBK1 impairs oncogenic Ras-induced anchorage-independent proliferation. Forty-eight hours posttransduction with GFP or Ras12V, WT,
and TBK/ MEFs were incubated with BrdU for 17 hr in adherent or suspension cultures. BrdU incorporation is represented as a percentage of the
total population. Error bars represent mean ± SD.
(D) Levels of oncogenic Ras expression tolerated by TBK1/ cells are insufficient to drive colony formation in soft agar. WT and TBK/MEFs trans-
duced with GFP or Ras12V as described in (A), were seeded in semisolid agar. After 10 days, numerous small colonies developed in response to Ras
expression in the WT MEFS. TBK1/ cells were unresponsive. Representative fields of view are shown from two independent analyses.
(E) TBK/ cells are sensitized to anoikis. 20 hr following release from matrix, DNA content of propidium iodide-stained cells was analyzed by FACS.
Representative results from three independent experiments are shown.166 Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc.
the Drs gene, encoding the antifungal peptide Drosomy-
cin, is a robust readout of Toll pathway activation in Dro-
sophila fat body cells (Hoffmann and Reichhart, 2002).
As shown in Figure 6K, either haploinsufficiency at the
Sec5 locus or reducingRal expressionwith a hypomorphic
mutation (Ral49D) blunts the response of fat body cells to
fungal invasion. While the observed defects are weak as
compared to a homozygous deletion of Spaetzle, the
Toll receptor ligand, they were reproducible and consis-
tent with a partial loss of function.
TBK1 Is Required for Oncogenic Transformation
The selective dependence of transformed cells on TBK1
suggests that establishment of a cell-autonomous tumor-
igenic regulatory network includes commandeering com-
ponents of innate immune signaling to deflect cell-death
checkpoint activation. This relationship predicts that
TBK null cells would be refractory to oncogenic transfor-
mation. To test this prediction, spontaneously immortal-
ized TBK1/ mouse embryonic fibroblasts and their
wild-type counterparts were infected with retrovirus en-
coding oncogenic K-ras (K-rasG12V) or GFP. Forty-eight
hours postinfection, the majority of the wild-type parental
MEFS infected by oncogenic Ras displayed disorganized
multilayered growth with the spindle-shaped, refractile
morphology typically observed in response to Ras. In con-
trast, the TBK/ MEFS accumulated a large number of
TUNEL-positive apoptotic cell bodies (Figure 7A). The tox-
icity associated with retroviral infection of the TBK/
MEFS was specific to Ras expression, as infection by
the identical retroviral backbone driving GFP expression
was well tolerated (Figures 7A and 7B). The TBK/
MEFS surviving oncogenic Ras transduction expressed
significantly less ectopic K-ras as compared to the paren-
tal cells, suggesting negative selection against high K-ras-
expressing cells in the absence of TBK1 (Figure 7B). The
amount of tolerated K-ras expression in TBK/ MEFS
only slightly enhanced MEK activation, failed to induce
AKT phosphorylation, and was associated with elevated
accumulation of cleaved PARP (Figure 7B). While onco-
genic K-ras transduction of the parental MEFS was suffi-
cient to support anchorage-independent proliferation
and the growth of colonies in soft agar, the amount of
K-ras expression in the TBK/ MEFS only weakly en-
hanced anchorage-independent proliferation (Figure 7C)
and failed to significantly promote colony-formation in
soft agar (Figure 7D). In fact, the TBK/ cells were them-
selves sensitized to the anoikis response as compared to
wild-type controls, much as we have observed upon de-
pletion of RalBor Sec5 in humanepithelial cells (Figure 7E).
These observations suggest TBK1 expression is required
for cells to tolerate transforming levels of oncogenic Ras
expression. In further support of this relationship, we
found that expression of kinase-dead TBK1 in oncogenicK-ras-expressing MEFs induced apoptosis, presumably
through dominant inhibition of native TBK1 activation (Fig-
ure 7F). Finally, we find that cancer cell lines (MCF7 and
Panc1) and oncogenic Ras transformedmammary epithe-
lial cells (HME-Ras12V) display elevated chronic TBK1 ki-
nase activity as compared to nontumorigenic mammary
epithelial cells (HME; Figure 7G).
DISCUSSION
Through elaboration of themolecular components directly
mediating RalB-dependent survival signaling in cancer
cells, we have identified a novel signal transduction cas-
cade connecting Ral activation to the atypical IKK family
kinase TBK1 and the cognate TBK1-dependent transcrip-
tion factors. We find that normal airway epithelial cells re-
quire a RalB/Sec5/TBK1 activation complex to support
the host defense response triggered by either extracellular
dsRNA or exposure to Sendai virus. Remarkably, this
pathway is chronically activated in cancer cells at the level
of RalB and is required to support pathological survival in
the context of a tumorigenic regulatory environment.
TBK1 is a central node in the regulatory network re-
quired to trigger host defense gene expression in the
face of a virally compromised environment. This kinase
is engaged downstream of multiple sentinel proteins in
the host defense response system (Beutler, 2004; Hiscott,
2004; Kato et al., 2006; Kawai et al., 2005; Lee et al., 2006;
McWhirter et al., 2005); however, the mechanistic basis of
TBK1 activation downstream of these triggers is largely
unknown. The adaptor protein TRIF is a TLR3-associated
molecule that is required to engage TBK1 activation and
can be found in a complex together with TBK1, TRAFs,
and IRF-3. However, the interaction of TBK1 with TRIF ap-
parently occurs subsequent to TBK1 activation, indicating
the presence of additional unknown factors proximally as-
sociated with TBK1 that lead to kinase activation (Sato
et al., 2003). One candidate is NAP1 (NAK-associated pro-
tein 1), a TANK-related protein that can enhance TBK1 ac-
tivation in vitro and is required for TLR3/4-activation of the
IFN-b promoter (Fujita et al., 2003). Here, we find that the
exocyst complex subunit and RalGTPase effector protein
Sec5 binds directly to TBK1 and is necessary and suffi-
cient to trigger TBK1 kinase activity in bronchial epithelial
cells. This interaction appears to be regulated by RalB-de-
pendent display of the TBK1 interaction interface on the
amino terminus of Sec5. Whether the RalB/Sec5/TBK1
activation complex functions independently of TRIF or
acts between TRIF and TBK1 remains to be determined.
The observation that Sec5 is required for both dsRNA-
and SenV-mediated IFN responses suggests that the
RalB/Sec5 effector complexmay be employed bymultiple
regulatory systems converging on TBK1 activation (Kato
et al., 2006).(F) Kinase-dead TBK1 expression induces apoptosis in Ras-transformed cells. The indicated constructs were expressed in K-ras transformed MEFs
derived from (A) for 48 hr. Apoptosis is indicated by TUNEL and PARP cleavage.
(G) TBK1 kinase activity in normal and transformed cell cultures. Endogenous TBK1 kinase activity was assayed as described in Figure 4B.Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc. 167
Sec5 is an integral component of the Sec6/8 complex,
or exocyst. This eight-subunit vesicle targeting machine
plays a central role in the generation and maintenance of
functionally specified plasmamembrane domains (Novick
and Guo, 2002). We found that the contribution of Sec5
to TBK1 activation occurs independently of exocyst integ-
rity. This highlights a regulatory role for Sec5 proteins
beyond their contribution to dynamic vesicle trafficking.
Nevertheless, TBK1 is clearly recruited to the exocyst
complex and is likely engaged by Sec5 from within that
context. We have not yet determined if there are any fun-
damental functional relationships between host defense
signaling and the exocyst. However, guilt by association
would suggest that these two systems are coupled to al-
low coordinate regulation of multiple dynamic processes
that facilitate an effective host defense response. Given
the obligatory role of the exocyst in endosomal trafficking
steps, localization of Sec5 to endosomal compartments
containing antiviral surveillance receptors may represent
adoption of a strategic location for generation of antiviral
signaling platforms.
We found that TBK1 is required to support oncogenic
Ras transformation, and TBK1 kinase activity is elevated
in transformed cells and required for their survival in cul-
ture. Widespread evidence indicates that apoptosis is
often a collateral consequence of pathological regulation
of cell-cycle machinery (Abrams and White, 2004). This
mechanistic coupling between cell-cycle and cell-death
pathways likely represents a key component of the cell-au-
tonomous restraints governing tissue homeostasis (Evan
and Vousden, 2001; Green and Evan, 2002). As a conse-
quence, oncogene-driven aberrations in the regulatory
networks of cancer cells can generate survival dependen-
cies on otherwise nonessential gene products (Lowe et al.,
2004). We have previously identified a key role for RalB
GTPase activity in the support of cell survival in the face
of oncogenic stress (Chien andWhite, 2003) andnowdem-
onstrate that a RalB/Sec5/TBK1 activation complex repre-
sents the functional core of that support. We have not yet
determined if there are specific prosurvival/antiapoptotic
components of the altered gene expression programs in-
duced by IRF-3 and IRF-7 in response to TBK1 activation
or if additional TBK1 substrates remain to be identified
that support cell survival. Of note, IRF-7 expression is suf-
ficient to promote anchorage-independent proliferation
and is significantly associated with the pathogenesis of
EBV-associated lymphomas (Zhang et al., 2004).
In summary, we have defined the mechanistic contribu-
tion of RalB to oncogenic transformation and revealed the
RalB/Sec5 effector complex as an obligatory component
of the proximal machinery engaging TBK1 activation in
response to antiviral surveillance signaling. The functional
relationship of the RalB/Sec5/TBK1 activation complex to
tumor cell survival suggests that oncogenic transformation
commandeers cell-autonomous host defense signaling
to deflect cell-death checkpoint activation. This relation-
ship reveals a novel aspect of the aberrant cell regulatory
programs supporting tumorigenicity and suggests pro-168 Cell 127, 157–170, October 6, 2006 ª2006 Elsevier Inc.teins like TBK1 may be conceptually ideal candidate tar-
gets for development of drugs with a large therapeutic
window.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
All human cell lines were handled as previously described (Chien and
White, 2003), except osteosarcoma cells were maintained in DMEM
with 10% FBS and transfected with Fugene 6 (Roche) and HBECs
were maintained in defined Keratinocyte-SFM medium (GIBCO).
siRNAs were delivered using Oligofectamine (Life Technologies) in all
cell lines. To obtain high-transfection efficiencies (>90%) of HMECs
and HBECs, cultures were exposed to trypsin to induce macropinocy-
tosis on apical and lateral surfaces (Chien and White, 2003).
Materials
Myc-RalF39L, HA-Sec5, Myc-RLIPrbd, Myc-Sec5-RBD, GST-
RLIPrbd, and GST-Sec5rbd constructs are as previously described
(Moskalenko et al., 2002). FLAG-TBK1 (WT), FLAG-TBK1 (K38A),
and GST-IRF-3C0 (residues 375–427) were kindly provided by Dr.
James Chen (UT Southwestern Medical Center). Synthetic siRNAs tar-
geting RalA and RalB were as previously described (Chien and White,
2003). Synthetic siRNAs targeting Sec5, Sec6, Sec8, Sec10, Exo84,
and TBK1 were designed by standardmethods (see Supplemental Ex-
perimental Procedures in the Supplemental Data available with this
article online). The following antibodies were used: mouse monoclonal
anti-RalA and rabbit polyclonal anti-RalB (BD, Transduction Laborato-
ries); rabbit polyclonal ERK1/2 (Santa Cruz Biotechnology); rabbit
polyclonal anti-Sec5, mouse monoclonal anti-Sec6; rabbit polyclonal
anti-Sec10, rabbit polyclonal anti-Exo84 (Moskalenko et al., 2002,
2003); rabbit polyclonal anti-IRF-3 (Santa Cruz Biotechnology); rabbit
polyclonal anti-phospho-IRF-3 (Ser396) (Upstate); and mouse mono-
clonal anti-TBK1/NAK (Imgenex), mouse monoclonal anti-Ras (BD),
and rabbit polyclonal anti-GFP (Santa Cruz Biotechnology). Phospho-
specific antibodies were purchased from Cell Signaling. Poly(I:C) was
reconstituted in PBS according to manufacturer’s instruction (Amer-
sham-Pharmacia). Sendai virus (Cantell strain, Charles River Laborato-
ries) was used at a concentration of 100 (HA) units/ml. IFN-bproduction
wasmeasured using the human IFN-b ELISA (PBL Biomedical Labora-
tories). TUNEL was carried out according to manufacturer’s instruc-
tions (BD, Biosciences).
Immunoprecipitation and Mass Spectrometry
Sec8-associated proteins were immunoprecipitated from 16 mg HeLa
cytosolic extracts prepared according to Dignam et al. (1983). Proteins
were eluted and separated by SDS-PAGE. Gels were stained with col-
loidal Coomassie blue (Invitrogen), and protein bands of interest were
excised and in-gel digested. The resulting tryptic peptides were iden-
tified as previously described (Zhao et al., 2004b). For all other IPs,
cells were lysed in 1%NP-40, 10mM Tris (pH 7.6), 250 mM sodium de-
oxycholate, 1mMMgCl2, 1mMEGTA, 10%glycerol, 150mMNaCl, 50
mM NaF, 1 mM sodium vanadate, and 80 mM b-glycerol phosphate.
Cleared supernatants were collected and incubated with antibody-
conjugated agarose for 2 hr. Beads were then washed four times in
lyses buffer plus 250 mM NaCl prior to immunoblot analysis.
In Vitro Binding and Protein Kinase Assays
Purified recombinant GST-RLIPrbd and GST-Sec5rbd were immobi-
lized on glutathione-Sepharose beads. Ten micrograms of each GST
fusion protein were incubated with 0.5 mg of recombinant TBK1 protein
(Upstate) for 1 hr at 4C. Beads were then wash four times with 50 mM
Tris (pH7.6), 0.3 M NaCl, and 0.1% Triton X-100 prior to SDS-PAGE
analysis. TBK1 I.P. kinase assays were as described (McWhirter
et al., 2004).
Ral and Ras Activation Assays
Cells were lysed in 50 mM Tris (pH 7.6), 10% glycerol, 200 mM NaCl,
2.5 mM MgCl2, and 1% triton X-100. Cleared supernatants were col-
lected and incubated with GST-Sec5rbd or GST-Raf1rbd immobilized
on glutathione-Sepharose beads for 1 hr at 4C. Beads were washed
three times with lysis buffer prior to SDS-PAGE analysis.
RT-PCR
Total RNAwas isolated fromHBEC cells using High Pure RNA Isolation
Kit (Roche) and subjected to RT-PCR using SuperScript III One-Step
RT-PCR system (Invitrogen) to measure expression of ISG56 and
GAPDH. Gene-specific primer sequences are described in Supple-
mental Experimental Procedures. Quantitative analysis of Drosophila
fat bodydrs expressionwasperformedaspreviously described (Leulier
et al., 2003).
Supplemental Data
Supplemental Data for this article include Supplemental Experimental
Procedures and can be foundwith this article online at http://www.cell.
com/cgi/content/full/127/1/157/DC1/.
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